21(81): 6-8 Amelung VE , Turina B, Wolf S. Medical apps on the rise - an opportunity for more efficient and effective healthcare. KU Health Management special: IT in the hospital 2013; 2: 8-11 Amelung [...] of Integrated Care Third Edition. Springer Nature. Seiten: 331-347. doi.org/10.1007/978-3-031-96286-8_14 Amelung VE , Himmler S, Stein V (2025). Strategic Management and Integrated Care in a Competitive [...] of Integrated Care Third Edition. Springer Nature. Seiten 433-447. doi.org/10.1007/978-3-031-96286-8_23 Arnold M, Klähn A-K, Amelung VE (2025). Overview of Study Designs. In: Amelung VE , Stein V, Suter
acid profiles of mice expressing variant allelic combinations of the polysialyltransferases ST8SiaII and ST8SiaIV. J. Biol. Chem. 281 (42):31605-15. Senkov, O. , Sun, M., Weinhold, B. , Gerardy-Schahn, [...] ent Mice Serve as a Model for Human Focal Segmental Glomerulosclerosis. J Am Soc Nephrol. 2019 Jun;30(6):1021-1035. 2018 Abeln M , Albers I, Peters-Bernard U, Flächsig-Schulz K, Kats E , Kispert A, Tomlinson [...] (corresponding author), Zharkovsky A (2015) Schizophrenia-like phenotype of polysialyltransferase ST8SIA2-deficient mice. Brain Struct. Funct. 220:71-83. Sellmeier M, Weinhold B , Münster-Kühnel A . CMP-sialic
(OS), objective response rate (ORR) and safety. The median PFS in the respective arms was 16.4 vs. 8.4 months (hazard ratio 0.58, 95% confidence interval [95% CI] 0.49-0.70), and the median OS was 46.5 [...] Patients received 4 cycles of nivolumab 360 mg every 3 weeks + paclitaxel 125 mg/m2 on days 1 and 8 every 3 weeks, followed by cystectomy and then 13 doses of nivolumab 360 mg every 3 weeks adjuvantly [...] n of the tumor disease during neoadjuvant treatment. After a median follow-up of 10.6 months (IQR: 8-16), one patient showed progression. The 12-month EFS was 96.4% (95%CI: 89.9-100). Overall, the abo
BH3-only proteins and expression in axolotl organs and apoptotic limb regeneration tissue. Biol Open. 7(8):bio036293. doi: 10.1242/bio.036293. Waqas SFH, Noble A, Hoang AC, Ampem G, Popp M, Strauß S, Guille [...] (Ambystoma mexicanum ) husbandry conditions, rearing and husbandry-related diseases. Amphibia 12(1):5-8. AbuQarn M, Allmeling C, Amshoff I, Menger B, Nasser I, Vogt PM, Reimers K (2011). The yeast two hybrid [...] husbandry and development of the Anderson's cross-toothed newt Ambystoma andersoni . Elaphe 2010, 18(3):30-38. Menger B, Jahn S, Allmeling C, Reimers K, Mutschmann F, Jacobsen ID, Vogt PM (2009). Therapy of
MO, DIE, DO 13:00-17:00; MI, FR 08:30-12:30 Mail advice: www.deutsche-depressionshilfe.de Peer-to-peer counseling Deutsche Angst-Hilfe e. V. Tel: 089 215 298 31 FR 8:00-12:00 Mail advice: www.angstselbsthilfe [...] kick-off event The kick-off event for "Mental Health Week" can be followed on October 10, 2014 from 5:30 p.m. in the livestream on the Action Alliance's YouTube channel. Registration is not necessary. Offers
infusion in patients with myelofibrosis after allogeneic stem cell transplantation. Blood 2009; 113(8): 1866-8 Kruse B, Thissen S, Warnecke G, Avsar M, Gottlieb J, Hohlfeld JM, Karstens JH, Kraever V, Länger [...] rare but distinct entity that can affect virgins and young adolescents Eur J Gynaecol Oncol 2009; 30(1): 45-8 Lordemann AG, Hjelle B, Theegarten D, Grabellus F, Schmid KW, Hoyer PF, Vester U, Becker JU: Young [...] steroid response in biopsy proven acute graft rejection after lung transplantation. Respir Med 2009; 103(8): 1114-1121 Gadzicki D, Schubert A, Fischer C, Milde S, Lehmann U, Steinemann D, Lück HJ, Kreipe H,
aspects | Part 1+2 16.09.2024 | 16 to approx. 19:15 | 3/ Patient empowerment and self-help | Part 1-3+5 30.09.2024 | 4 p.m. to approx. 7:15 p.m. | 2/ Challenging situations and self-care | Part 1-3 22.10.2024 [...] n | Part 2+3 21.11.2024 | 4 p.m. to approx. 7:15 p.m. | 5/ Diseases and treatment options | Part 2+8 21.11.2024 | 16 to approx. 19:15 | 3/ Patient empowerment and self-help | Part 4 21.11.2024 | 4 p.m
and form a metastasis there, for example in the brain. On the occasion of World Brain Tumor Day on 8 June 2023, we talk to senior physician Dr. med. Majid Esmaeilzadeh from the Neurooncology Center at [...] lifestyle helps to reduce the risk of developing cancer. How common are metastases in the brain? In 20 to 30 percent of all cancer patients with systemic metastasis, metastases develop in the brain. The most
d4585. Science. 2020 Oct 23;370(6515):eabd4570. ; J Allergy Clin Immunol Pract 2020 Oct 8;S2213-2198(20)31102-8. doi: 10.1016/j.jaip.2020.09.052. Online ahead of print). It has also been shown that au [...] general risk factors include Severe lung or heart disease Diabetes mellitus Body mass index (BMI) over 30 Age over 60 years. The following specific risk factors are also relevant: Severe pulmonary viral infections [...] immunodeficiency? In a recently published paper (J Allergy Clin Immunol. 2020 Sep 24;S0091-6749(20)31320-8.), 94 patients (different age groups) with congenital immunodeficiencies who had undergone SARS-CoV-2
persistently activates endothelial Akt and attenuates progressive organ failure. Circulation 2004; 110(8): 1006-12 Bock O, Neusch M, Büsche G, Mengel M, Kreipe H: Constitutive expression of the FK506 binding [...] Lehmann U: Low level of DAP kinase methylation in myelodysplastic syndrome. Blood 2004; 104(5): 1586-8 [letter] Breuhahn K, Vreden S, Haddad R, Beckebaum S, Stippel D, Flemming P, Nussbaum T, Caselmann WH [...] hepatocellular carcinoma according to new staging classifications. Dtsch Med Wochenschr 2004; 129(33): 1725-30 Dahlke MH, Aselmann H, Ceylan D, Bellin T, Flemming P, Meier PN, Oldhafer K, Klempnauer J, Schlitt